We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Screening Tool Evaluated for Urinary Infection Diagnosis

By LabMedica International staff writers
Posted on 31 Oct 2013
Print article
Image: The UriSed automatic urine sediment analyzer (Photo courtesy of 77 Elektronika Kft).
Image: The UriSed automatic urine sediment analyzer (Photo courtesy of 77 Elektronika Kft).
A quantitative urine culture is essential for the final diagnosis of urinary tract infection (UTI), but it is time-consuming and an expensive procedure.

Effective screening tests would be a promising alternative to provide immediate results for the clinician and eliminate unnecessary culturing for most of the negative samples.

Laboratory scientists at the University of Campinas (Brazil) evaluated 1,379 clean-catch midstream urine samples from inpatients and outpatients. This included 1,006 females and 373 males, age ranging from two months to 90 years, with a median age of 41 years. Three hundred ninety-nine patients (29%) had renal diseases, including kidney transplantation and functional or anatomical abnormalities of the urinary system and 8% of the cases were pregnant women.

All samples were submitted to automated sediment analysis called UriSed (77 Elektronika Kft; Budapest, Hungary) and quantitative urine culture on Cystine-Lactose-Electrolyte-Deficient Agar (CLED) (Becton Dickinson; Franklin Lakes, NJ, USA). The cut-off values for leukocyturia and significant bacteriuria were established by comparing the results obtained by UriSed and by urine culture.

From all the 1,379 analyzed urine samples, 664 of these (48%) were classified as positive for UTI by UriSed and 715 (52%) samples were classified as negative. Urine culture was positive in 13% of the samples (183/1,379). As expected, Escherichia coli was the most common microorganism isolated (84/183), followed by Klebsiella spp. (16/183) and Proteus spp. (8/183).

The sediment analyzer detected leukocyturia and/or significant bacteriuria with sensitivity of 97%, specificity of 59%, positive predictive value of 27%, negative predictive value of 99%, and accuracy of 64% at cutoff values of bacteria count equal to or greater than 12.6 elements/ high-power field (hpf) and white blood cells (WBC) equal to or greater than 6 cells/hpf. These data suggest a potential 52% reduction of unnecessary urine cultures.

The authors concluded that the UriSed system appears to be an efficient tool to rule out UTI with high sensitivity (97%) and low rate of false-negative results (1%) and thus reduce unnecessary urine cultures. However, a positive screen does not necessarily indicate UTI and should be confirmed by urine culture. The study was published on October 21, 2013, in the journal Clinica Chimica Acta.

Related Links:

University of Campinas
77 Elektronika Kft 
Becton Dickinson


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.